Organization
Trefoil Therapeutics
4 clinical trials
Clinical trial
Phase 2 Study To Determine the Safety and Efficacy of TTHX1114(NM141) on the Regeneration and Migration of Corneal Endothelial Cells in Patients Undergoing DWEK/DSOStatus: Completed, Estimated PCD: 2022-11-16
Clinical trial
A Phase 1 Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of TTHX1114(NM141) Ophthalmic Solution In Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-04-12
Clinical trial
A Phase 1/ Phase 2 Study Evaluating the Safety and Efficacy of the Investigational New Drug TTHX1114(NM141) on the Regeneration of Corneal Endothelial Cells in Patients With Corneal Endothelial Dystrophies Following Intracameral DeliveryStatus: Completed, Estimated PCD: 2021-04-23
Clinical trial
A Phase 2 Clinical Trial to Assess the Safety and Observe the Potential Benefit of TTHX1114 Delivered Via Intra-Cameral (IC) InjectionStatus: Completed, Estimated PCD: 2023-08-29